Pharmacovigilance in Poland

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue 4, 1997, Pages 277-281

  Czarnecki, Andrzej ^a   Maciejczyk, Agata ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Adverse drug reaction; Drug safety monitoring; Pharmacovigilance

Indexed keywords

ANTIBIOTIC AGENT; CARDIOVASCULAR AGENT; CONTRAST MEDIUM; DRUG;

ADVERSE DRUG REACTION; ARTICLE; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; INFORMATION PROCESSING; POLAND; PRIORITY JOURNAL;

EID: 0030777244     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199707)6:4<277::AID-PDS268>3.0.CO;2-I     Document Type: Article

References (14)

1. Edwards, I. R. WHO Programme for International Drug Monitoring I. Drug Information Journal 1992; 26: 477-480.
2. Edwards, I. R. and Lindquist, M. WHO Programme for International Drug Monitoring H. Drug Information Journal 1992; 26: 481-486.
3. Rudzki, E., Stodolnik, E. and Chrusciel T. L. Rumienie polekowe. Przeglałd Dermatol. 1983; 1: 37-42.
4. Stodolnik, E. et al. Risk of acute upper gastrointestinal bleeding in patients with ulcerative disease and treatment with non-steroidal anti-inflammatory drugs (NSAIDs). Results from the comprehensive hospital drug monitoring Berne (CHDM). European Journal of Clinical Pharmacology 1990; 1: 31-36.
5. Guzecka-Ruszczyńska, E. and Czarnecki, A. Analysis of pharmacotherapy and its effectiveness in ischaemic heart disease and arterial hypertension, conducted by doctors in specialist and regional outpatient clinics. Wiadomości Lekarskie 1994; 57(9-10): 352.
6. Czarnecki, A. and Ruszczynska, E. A comparative study of patients with ischaemic heart disease (IHD) and arterial hypertension (AH) treated by cardiologists and general practitioners (GP). Second European Pharmacovigilance Symposium, Paris, France 26-27 November 1992.
7. Kot, T. and Czarnecki, A. Registration of drug products in Poland, 1989-1993. Journal of Regulatory Affairs 1995; 6: 14-21.
8. IBID. ISDB Newsletter 1994; 8: 10.
9. Czarnecki, A. Pseudomembranaceous colitis due to antibiotic therapy. Biuletyn Leków 1993; 2: 3-5.
10. Czarnecki, A. Safety of pharmacotherapy. Gazeta Lekarska 1993; 4: 18.
11. Czarnecki, A. Bezpieczeństwo stosowania leków. British Medical Journal (Polish edn) 1996; 2: 60.
12. Ustawa o Środkach Farmaceutycznych, Materiałach Medycznych, Aptekach, Hurtowniach i Nadzorze Farmaceutycznym. Dziennik Ustaw RP 1991; 105: 1406-1414.
13. Kot, T. and Czarnecki, A. GCP in Poland: status and current practice and research institutions. Applied Clinical Trials 1993; 2: 52-57.
14. Czarnecki, A. Central Register of Clinical Trials: current status of clinical research in Poland. Drug Information Journal in press.